Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma
- PMID: 30481787
- DOI: 10.1159/000495554
Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma
Retraction in
-
Retraction Statement.Cell Physiol Biochem. 2021;55(4):515. doi: 10.33594/000000407. Cell Physiol Biochem. 2021. PMID: 34735061 No abstract available.
Abstract
Background/aims: Novel long non-coding RNA Fer-1-like protein 4 (FER1L4) has been reported to play crucial regulatory roles in tumor progression. However, its clinical significance and biological role in osteosarcoma (OS) is completely unknown. The aim of the present study was to investigate the role of FER1L4 in OS progression and the underlying mechanism.
Methods: We analyzed the expression levels of FER1L4 in tissues of OS patients and cell lines via quantitative RT-PCR (qRT-PCR). The effect of FER1L4 on cell proliferation, colony formation, migration and invasion was analyzed by cell counting kit-8 (CCK-8), colony formation, wound healing and transwell invasion assay, respectively. Novel targets of FER1L4 were selected through a bioinformatics soft and confirmed using a dual-luciferase reporter system and qRT-PCR. To detect the role of FER1L4 in vivo tumorigenesis, tumor xenografts were created.
Results: We found that the expression of FER1L4 was significantly downregulated in OS tissues and cell lines; moreover, low expression of FER1L4 was associated with advanced tumor-nude-metastasis (TNM) stage, lymph node metastases, and poor overall survival. Functional assays showed that upregulation of FER1L4 significantly inhibited OS cell proliferation, colony formation, migration, and invasion in vitro, as well as suppressed tumor growth in vivo. Assays performed to determine the underlying mechanism, indicated that FER1L4 interacted directly with miR-18a-5p. Subsequently, we found that FER1L4 significantly increased PTEN expression, a known target of miR-18a-5p, in OS cells. Furthermore, PTEN was found to be down-regulated, and positively correlated with FER1L4 in OS tissues.
Conclusion: These findings suggest that FER1L4, acting as a competing endogenous RNA (ceRNA) of miR-18a-5p, exerts its anti-cancer role by modulating the expression of PTEN. Thus, FER1L4 may be a novel target for the prevention and treatment of OS.
Keywords: FERIL4; Long non-coding RNA; Osteosarcoma; PTEN; miR-18a-5p.
© 2018 The Author(s). Published by S. Karger AG, Basel.
Similar articles
-
LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.Gene. 2019 Dec 30;721:144093. doi: 10.1016/j.gene.2019.144093. Epub 2019 Aug 29. Gene. 2019. PMID: 31473323
-
Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.Mol Cancer. 2018 May 12;17(1):89. doi: 10.1186/s12943-018-0837-6. Mol Cancer. 2018. PMID: 29753317 Free PMC article.
-
Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.Cancer Sci. 2015 Oct;106(10):1323-32. doi: 10.1111/cas.12759. Epub 2015 Sep 21. Cancer Sci. 2015. PMID: 26224446 Free PMC article.
-
FER1L4: A Long Non-coding RNA with Multiple Roles in the Occurrence and Development of Tumors.Curr Pharm Des. 2022;28(16):1334-1341. doi: 10.2174/1381612828666220324141016. Curr Pharm Des. 2022. PMID: 35331091 Review.
-
The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).Int J Oncol. 2021 Sep;59(3):69. doi: 10.3892/ijo.2021.5249. Epub 2021 Jul 23. Int J Oncol. 2021. PMID: 34296296 Review.
Cited by
-
Therapeutic potential of extracellular vesicle-associated long noncoding RNA.Bioeng Transl Med. 2020 Jul 16;5(3):e10172. doi: 10.1002/btm2.10172. eCollection 2020 Sep. Bioeng Transl Med. 2020. PMID: 33005738 Free PMC article. Review.
-
The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.BMC Cancer. 2021 Feb 27;21(1):202. doi: 10.1186/s12885-021-07882-w. BMC Cancer. 2021. PMID: 33639865 Free PMC article.
-
Circular RNA expression profiles in the plasma of patients with infantile hemangioma determined using microarray analysis.Exp Ther Med. 2021 Jun;21(6):634. doi: 10.3892/etm.2021.10066. Epub 2021 Apr 15. Exp Ther Med. 2021. PMID: 33968165 Free PMC article.
-
The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets.Front Cell Dev Biol. 2022 Feb 16;10:773038. doi: 10.3389/fcell.2022.773038. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252166 Free PMC article. Review.
-
Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p.Onco Targets Ther. 2019 Dec 6;12:10717-10726. doi: 10.2147/OTT.S219797. eCollection 2019. Onco Targets Ther. 2019. PMID: 31827329 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials